Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000–2005
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean regionInternational Journal of Antimicrobial Agents, 2007
- Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysisThe Lancet, 2007
- Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar)Vaccine, 2007
- Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998–2006)Vaccine, 2007
- Pneumococcal disease surveillance in EuropeEurosurveillance, 2006
- Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate VaccineJAMA, 2005
- Pneumococcal vaccination policy in EuropeEurosurveillance, 2005
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Epidemiology of invasive pneumococcal infections in children aged 0–6 years in Denmark: a 19‐year nationwide surveillance studyActa Paediatrica, 2000
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000